Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 88,504 shares at $9.89 ($875K) on 2023-02-28, disclosed to the SEC on 2023-03-02.
Seasonal sale ($875k) by Executive VP, European Commercial — this insider has traded TEVA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.89 | 20,598 | $204K | 23.3% |
| 2 | $9.89 | 20,598 | $204K | 23.3% |
| 3 | $9.89 | 23,654 | $234K | 26.7% |
| 4 | $9.89 | 23,654 | $234K | 26.7% |
| Total | $9.89 avg | 88,504 | $875K | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |